Table 3 The univariate and multivariate analysis of post-operative LTL and clinicopathologic variables associated with DFS in in the resectable NSCLC patients.
From: Leukocyte telomere length serves as the novel prognostic biomarker for the resectable NSCLC
Characteristics | Univariate analysis | Multivariate analysis | ||
|---|---|---|---|---|
HR (95% CI) | P value | HR (95% CI) | P value | |
Age (≥ 61vs < 61) | 1.156 (0.543–2.460) | 0.707 | 0.981 (0.432–2.225) | 0.963 |
Smoke | 1.659 (0.775–3.552) | 0.192 | 1.545 (0.636–3.754) | 0.336 |
LTL (high group vs. low group) | 0.778 (0.364–1.663) | 0.517 | 0.813 (0.365–1.810) | 0.612 |
Stage (3 + 4 vs. 1 + 2) | 2.909 (1.352–6.256) | 0.006* | 1.969 (0.669–5.799) | 0.219 |
N stage (positive vs. negative) | 2.741 (1.246–6.030) | 0.012* | 2.011 (0.770–5.256) | 0.154 |
M stage (positive vs. negative) | 1.286 (0.386–4.287) | 0.682 | 0.704 (0.175–3.823) | 0.620 |
